Executing A Biopharma IPO In March 2020
Source: Life Science Leader
In this executive virtual roundtable (EVR) section (view full video here), Rahul Ballal, Ph.D., CEO of Imara, a clinical-stage biopharmaceutical company, shares the story of going public in early March as the COVID-19 pandemic swiftly approaches.
This website uses cookies to ensure you get the best experience on our website. Learn more